Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential.
Giner-Calabuig M, De Leon S, Wang J, Fehlmann TD, Ukaegbu C, Gibson J, Alustiza-Fernandez M, Pico MD, Alenda C, Herraiz M, Carrillo-Palau M, Salces I, Reyes J, Ortega SP, Obrador-Hevia A, Cecchini M, Syngal S, Stoffel E, Ellis NA, Sweasy J, Jover R, Llor X, Xicola RM.
Giner-Calabuig M, et al.
Br J Cancer. 2022 Jun;126(11):1595-1603. doi: 10.1038/s41416-022-01754-1. Epub 2022 Feb 23.
Br J Cancer. 2022.
PMID: 35197584
Free PMC article.